Transformation of Ginsenoside-rich Fraction Isolated from Ginseng (Panax ginseng) Leaves Induces Compound K

被引:5
作者
Kim, Sang Hyek [1 ]
Kim, Seong Yeong [2 ]
Lee, Ho [1 ]
Ra, Kyung Soo [3 ]
Suh, Hyung Joo [4 ]
Kim, Sun Young [5 ]
Shin, Kwang-Soon [1 ]
机构
[1] Kyonggi Univ, Dept Food Sci & Biotechnol, Suwon 443760, Gyeonggi, South Korea
[2] Kyonggi Univ, Grad Sch Educ, Suwon 443760, Gyeonggi, South Korea
[3] Daegu Tech Coll, Dept Food & Nutr, Taegu 704721, South Korea
[4] Korea Univ, Dept Food & Nutr, Seoul 136701, South Korea
[5] Hongcheon Inst Med Herb, Hongcheon 250930, Gangwon, South Korea
关键词
ginseng leaf; ginsenoside-rich fraction; transformation; absorbable metabolite; Compound K; DEGRADATION; RB-1;
D O I
10.1007/s10068-011-0163-x
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
To develop the new physiologically active materials from ginseng (Panax ginseng C. A. Meyer) leaves, the ginsenoside-rich fraction (GL-1) was isolated and transformed into highly absorbable metabolites in the gastrointestinal (GI) tract. To transform the ginsenosides in GL-1 into deglycosylated ginsenosides, GL-1 was treated with organic acids (0.1 and 1% lactic and acetic acid solutions) and fermented with isolated strains (P1-P4, and M3) from red ginseng extract for 7 days. The treatment of 0.1% lactic acid of GL-1 induced the highest transforms of partially-deglycosylated ginsenosides such as Mc, F2, and Rg3 (intermediate metabolites). On the other hand, Compound K (Compd K, final metabolite) contents in GL1 ferments with strain M3 showed about 6-time higher than that of control (not fermented). Consequently, the strain M3 was finally selected for the mass production of Compd K with well-absorbable property in GI tract and physiological activity.
引用
收藏
页码:1179 / 1186
页数:8
相关论文
共 23 条
[1]   Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng [J].
Akao, T ;
Kida, H ;
Kanaoka, M ;
Hattori, M ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) :1155-1160
[2]   Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity [J].
Bae, EA ;
Choo, MK ;
Park, EK ;
Park, SY ;
Shin, HY ;
Kim, DH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (06) :743-747
[3]  
Bae Eun-Ah, 2003, Journal of Microbiology and Biotechnology, V13, P9
[4]   NEW METHOD FOR QUANTITATIVE-DETERMINATION OF URONIC ACIDS [J].
BLUMENKR.N ;
ASBOEHAN.G .
ANALYTICAL BIOCHEMISTRY, 1973, 54 (02) :484-489
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Transformation of ginsenosides Rb2 and Rc from Panax ginseng by food microorganisms [J].
Chi, H ;
Kim, DH ;
Ji, GE .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (11) :2102-2105
[7]   DEGRADATION OF GINSENG SAPONINS UNDER MILD ACIDIC CONDITIONS [J].
HAN, BH ;
PARK, MH ;
HAN, YN ;
WOO, LK ;
SANKAWA, U ;
YAHARA, S ;
TANAKA, O .
PLANTA MEDICA, 1982, 44 (03) :146-149
[8]   Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent [J].
Hasegawa, H ;
Sung, JH ;
Huh, JD .
ARCHIVES OF PHARMACAL RESEARCH, 1997, 20 (06) :539-544
[9]   Optimization of ginsenosides hydrolyzing β-glucosidase production from Aspergillus niger using response surface methodology [J].
Hu, Jing-Ning ;
Zhu, Xue-Mei ;
Lee, Ki-Teak ;
Zheng, Yi-Nan ;
Li, Wei ;
Han, Li-Kun ;
Fang, Zhe-Ming ;
Gu, Li-Juan ;
Sun, Bai-Sheng ;
Wang, Chun-Yan ;
Sung, Chang-Kuen .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) :1870-1874
[10]  
Kim MW, 1987, KOREAN J GINSENG SCI, V11, P10